INR 89.26
(-2.42%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1.09 Billion INR | -28.01% |
2022 | 352.58 Million INR | 40.86% |
2021 | 250.31 Million INR | 4.06% |
2020 | 240.55 Million INR | 135.82% |
2019 | 102 Million INR | -67.68% |
2018 | 315.56 Million INR | 15.04% |
2017 | 274.31 Million INR | 15.23% |
2016 | 238.05 Million INR | 9.5% |
2015 | 217.39 Million INR | 47.59% |
2014 | 147.29 Million INR | -22.17% |
2013 | 189.26 Million INR | -19.88% |
2012 | 236.22 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 30.94 Million INR | -73.65% |
2023 Q1 | 8.04 Million INR | -92.83% |
2023 FY | 253.82 Million INR | -28.01% |
2023 Q4 | 117.42 Million INR | 34.81% |
2023 Q3 | 87.1 Million INR | 66.26% |
2023 Q2 | 52.38 Million INR | 551.43% |
2022 Q1 | 69.12 Million INR | -35.48% |
2022 FY | 352.58 Million INR | 40.86% |
2022 Q4 | 112.13 Million INR | -3.32% |
2022 Q3 | 115.98 Million INR | 24.58% |
2022 Q2 | 93.1 Million INR | 34.69% |
2021 FY | 250.31 Million INR | 4.06% |
2021 Q2 | 59.1 Million INR | 266.81% |
2021 Q4 | 107.14 Million INR | 56.44% |
2021 Q3 | 68.49 Million INR | 15.88% |
2021 Q1 | 16.11 Million INR | -70.82% |
2020 FY | 240.55 Million INR | 135.82% |
2020 Q3 | 36.34 Million INR | -58.97% |
2020 Q2 | 88.57 Million INR | 32.02% |
2020 Q1 | 67.09 Million INR | 32.84% |
2020 Q4 | 55.22 Million INR | 51.96% |
2019 Q1 | -2.46 Million INR | -103.09% |
2019 FY | 102 Million INR | -67.68% |
2019 Q4 | 50.5 Million INR | 18.5% |
2019 Q3 | 42.61 Million INR | 275.63% |
2019 Q2 | 11.34 Million INR | 560.66% |
2018 Q4 | 79.66 Million INR | -19.2% |
2018 FY | 315.56 Million INR | 15.04% |
2018 Q3 | 98.59 Million INR | 31.75% |
2018 Q2 | 74.83 Million INR | 19.82% |
2018 Q1 | 62.46 Million INR | -30.04% |
2017 Q3 | 84.12 Million INR | 47.97% |
2017 Q1 | 44.05 Million INR | 0.0% |
2017 Q2 | 56.85 Million INR | 29.04% |
2017 Q4 | 89.28 Million INR | 6.14% |
2017 FY | 274.31 Million INR | 15.23% |
2016 FY | 238.05 Million INR | 9.5% |
2015 FY | 217.39 Million INR | 47.59% |
2014 FY | 147.29 Million INR | -22.17% |
2013 FY | 189.26 Million INR | -19.88% |
2012 FY | 236.22 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Hester Biosciences Limited | 364.77 Million INR | -201.043% |
Albert David Limited | 1.33 Billion INR | 17.711% |
Alembic Limited | 767.77 Million INR | -43.026% |
Alkem Laboratories Limited | 19.46 Billion INR | 94.358% |
Alembic Pharmaceuticals Limited | 5.75 Billion INR | 80.929% |
Bafna Pharmaceuticals Limited | 237.66 Million INR | -362.05% |
Bajaj HealthCare Limited | - INR | -Infinity% |
FDC Limited | 3.03 Billion INR | 63.803% |
Glenmark Life Sciences Limited | 8.97 Billion INR | 87.77% |
Gufic Biosciences Limited | 2.89 Billion INR | 62.053% |
Hikal Limited | 1.49 Billion INR | 26.508% |
Ind-Swift Laboratories Limited | 2 Billion INR | 45.341% |
Ind-Swift Limited | 1.22 Billion INR | 10.429% |
Innova Captab Limited | 2.53 Billion INR | 56.655% |
Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -413.041% |
Jubilant Pharmova Limited | 5.18 Billion INR | 78.838% |
Kilitch Drugs (India) Limited | 208.05 Million INR | -427.812% |
Laurus Labs Limited | 3.94 Billion INR | 72.19% |
Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 42.396% |
Lupin Limited | 27.75 Billion INR | 96.044% |
Mangalam Drugs & Organics Limited | 27.45 Million INR | -3899.246% |
Medico Remedies Limited | 277.11 Million INR | -296.262% |
Morepen Laboratories Limited | 4.17 Billion INR | 73.691% |
Nectar Lifesciences Limited | 3.89 Billion INR | 71.775% |
Orchid Pharma Limited | 2.36 Billion INR | 53.491% |
Procter & Gamble Health Limited | 2.78 Billion INR | 60.585% |
RPG Life Sciences Limited | 2.29 Billion INR | 52.096% |
Solara Active Pharma Sciences Limited | -3.85 Billion INR | 128.501% |
Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.947% |
Suven Pharmaceuticals Limited | 4.6 Billion INR | 76.168% |
Themis Medicare Limited | 1.3 Billion INR | 15.731% |
Unichem Laboratories Limited | - INR | -Infinity% |
Vaishali Pharma Limited | 6.29 Million INR | -17346.981% |
Venus Remedies Limited | 534.65 Million INR | -105.389% |
Wanbury Limited | 1.7 Billion INR | 35.678% |
Windlas Biotech Limited | 1.29 Billion INR | 15.458% |
Ipca Laboratories Limited | 29.59 Billion INR | 96.29% |
Aarti Drugs Limited | 7.14 Billion INR | 84.639% |
Aarti Pharmalabs Limited | 3.12 Billion INR | 64.895% |
Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -5216.194% |
Brooks Laboratories Limited | -72.25 Million INR | 1619.838% |
Eris Lifesciences Limited | 5.18 Billion INR | 78.808% |
IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 77.781% |
Sigachi Industries Limited | 1.47 Billion INR | 25.496% |
Sakar Healthcare Limited | 495.5 Million INR | -121.614% |
Aurobindo Pharma Limited | 104.5 Billion INR | 98.949% |
Divi's Laboratories Limited | 18.31 Billion INR | 94.003% |
AstraZeneca Pharma India Limited | 4.47 Billion INR | 75.455% |
Mankind Pharma Limited | 40.86 Billion INR | 97.313% |
Sequent Scientific Limited | - INR | -Infinity% |
Neuland Laboratories Limited | 5.31 Billion INR | 79.351% |
J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 85.439% |
Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 83.112% |
Zydus Lifesciences Limited | 45.39 Billion INR | 97.581% |
Amrutanjan Health Care Limited | 621.02 Million INR | -76.822% |
Wockhardt Limited | 140 Million INR | -684.366% |
Bal Pharma Limited | 214.56 Million INR | -411.776% |
Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 98.379% |
Bliss GVS Pharma Limited | 1.23 Billion INR | 10.795% |
Par Drugs and Chemicals Limited | 551.58 Million INR | -99.082% |
Caplin Point Laboratories Limited | 7.22 Billion INR | 84.802% |
Shilpa Medicare Limited | 3.76 Billion INR | 70.807% |
Valiant Laboratories Limited | - INR | -Infinity% |
Ajanta Pharma Limited | 19.67 Billion INR | 94.419% |
Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -38691.257% |
Granules India Limited | 6.52 Billion INR | 83.179% |
Medicamen Biotech Limited | - INR | -Infinity% |
Syncom Formulations (India) Limited | 249.25 Million INR | -340.565% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 25.33 Billion INR | 95.666% |
NATCO Pharma Limited | 25.96 Billion INR | 95.77% |
Suven Life Sciences Limited | -1.22 Billion INR | 189.582% |
Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
Strides Pharma Science Limited | 5.22 Billion INR | 78.987% |
Indoco Remedies Limited | 1.52 Billion INR | 27.964% |
Alpa Laboratories Limited | 61.51 Million INR | -1685.114% |
Lasa Supergenerics Limited | -458 Million INR | 339.76% |
Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 126.685% |